Om

Alebund Pharmaceuticals (Jiangsu) Limited is a biopharmaceutical company focused on renal therapies and related chronic conditions. Alebund Pharmaceuticals develops, manufactures, and commercializes innovative medicines for kidney diseases, with a pipeline that includes treatments for hyperphosphatemia, renal anemia, IgA nephropathy, diabetic kidney disease, focal segmental glomerulosclerosis, and autosomal dominant polycystic kidney disease. Its product portfolio combines clinical and preclinical candidates with an approved commercial product, reflecting a business centered on both research-driven development and market delivery. The company also maintains manufacturing capabilities and a specialized nephrology sales team to support commercialization in China. Alebund Pharmaceuticals plays a specialized role in the healthcare market by addressing unmet needs in nephrology through targeted therapies and a focused renal product portfolio.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ALEBUND PHARMACEUTICALS JIANGSU MED ENDAVU: Køb Alebund Pharmaceuticals Jiangsu ($9637) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Alebund Pharmaceuticals Jiangsu, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.